Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
about
The immunoregulatory role of type I and type II NKT cells in cancer and other diseasesDendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.The split personality of NKT cells in malignancy, autoimmune and allergic disordersExpression of CD1a and Type-1 Polarization Are Dissociated in Human Monocyte-Derived Dendritic CellsBoosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvantsFunctional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.Immunosuppressive roles of natural killer T (NKT) cells in the skin.Induction of Bcl-xL-specific cytotoxic T lymphocytes in mice.Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.Natural Killer T Cells in Cancer ImmunotherapyPolyinosinic-cytidylic acid as an adjuvant on natural killer- and dendritic cell-mediated antitumor activities.A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.Tissue-Specific Roles of NKT Cells in Tumor Immunity
P2860
Q27027556-49FE7104-BAD1-41B8-B14C-DB60D4511D7CQ33733648-BFD7BD97-F28D-4D36-88AE-D2A96360CF4AQ35590727-727492A3-2BD8-4A5B-B5D5-DEDE2C2D2C3EQ35804487-79CD4866-1A45-4F96-B8BE-F972158364DFQ36474450-0D52CA5A-F2A4-4D06-8BCC-B238E906EB2DQ36862410-0B3C3351-ACE8-49E8-B809-9E1C41ED9AD5Q38209646-DB1248CA-38AE-4F47-8F09-FA164B264E3FQ38993215-179CFD2B-489E-4EA3-8C16-55ACEA6094B7Q39254820-3D140342-76CC-429A-AE6E-454C14B545E8Q41358662-B6371EAA-FD2C-42FB-AB22-A978C128321CQ42078314-FA35C5FC-E5DA-402E-8AD8-CE77F99F29BAQ42273935-29F5FE46-F867-4682-AD8C-0658A833DEC4Q52822549-21EBB9D5-E947-473D-ABF1-BDF1590E385EQ58777562-8469D4AB-A566-42D0-9CA8-C647BAD0F658
P2860
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@en
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@nl
type
label
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@en
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@nl
prefLabel
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@en
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@nl
P2093
P2860
P50
P356
P1476
Potent anti-tumor responses to ...... tissue and an NKT cell ligand.
@en
P2093
Deborah A Knight
Franca Ronchese
Kathryn J Farrand
Nina Dickgreber
P2860
P304
P356
10.1038/ICB.2010.9
P577
2010-02-09T00:00:00Z